Jonas Kügler
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Biotechnology top 10%
- Transgenic Plants and Applications
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
-
- Glycosylation and Glycoproteins Research 5
- Protein purification and stability 4
- Advanced Biosensing Techniques and Applications 2
- Co-authors
- Michael Hust (9 shared papers)André Frenzel (7 shared papers)Thomas Schirrmann (4 shared papers)Stefan Dübel (4 shared papers)Doris Meier (2 shared papers)Lars Toleikis (2 shared papers)Björn Hock (1 shared paper)Torsten Meyer (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)BMC Biotechnology (2 papers)Applied Microbiology and Biotechnology (1 paper)Biotechnology and Bioengineering (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Jonas Kügler
16 papers receiving 436 citations
Peers
Comparison fields: 5 of 55
- Radiology, Nuclear Medicine and Imaging 244
- Biotechnology 48
- Hematology 42
- Molecular Biology 255
- Immunology 67
Countries citing papers authored by Jonas Kügler
This map shows the geographic impact of Jonas Kügler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Kügler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Kügler more than expected).
Fields of papers citing papers by Jonas Kügler
This network shows the impact of papers produced by Jonas Kügler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Kügler. The network helps show where Jonas Kügler may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Kügler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 103 | |
| 2 | 2017 | 61 | |
| 3 | 2013 | 41 | |
| 4 | Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. | 2006 | 37 |
| 5 | 2013 | 34 | |
| 6 | 2017 | 32 | |
| 7 | 2008 | 30 | |
| 8 | 2020 | 24 | |
| 9 | 2008 | 22 | |
| 10 | 2012 | 20 | |
| 11 | 2015 | 18 | |
| 12 | 2017 | 11 | |
| 13 | 2008 | 5 | |
| 14 | 2007 | 3 | |
| 15 | 2001 | 3 | |
| 16 | 2008 | 2 | |
| 17 | 2018 | 0 |
About Jonas Kügler
Jonas Kügler is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 446 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers), Protein purification and stability (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Bacteriophages and microbial interactions (2 papers), Advanced Biosensing Techniques and Applications (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Transgenic Plants and Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (244 citations), Biotechnology (48 citations), Hematology (42 citations), Molecular Biology (255 citations) and Immunology (67 citations). Jonas Kügler has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Michael Hust, André Frenzel, Thomas Schirrmann, Stefan Dübel, Doris Meier, Lars Toleikis, Björn Hock, Torsten Meyer, Mark Schütte and Henk Garritsen. Their work appears in journals such as Journal of Clinical Oncology, BMC Biotechnology, Applied Microbiology and Biotechnology, Biotechnology and Bioengineering and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.